Sangeeta N Bhatia

USPTO Granted Patents = 60 (Patent Applications = 38)

CIPO Patents = 4 (Patent Applications = 13)

EPO Patents = 10 (Patent Applications = 32)

Average Co-Inventor Count = 3.2

ph-index = 13

Forward Citations = 926(Granted Patents)

Forward Citations (Not Self Cited) = 778(Dec 10, 2025)

Inventors with similar research interests:

Location History:

La Jolla, CA (US) (2003 - 2014)
Cambridge, MA (US) (1998 - 2023)
Lexington, MA (US) (2011 - 2024)

Company Filing History:

44 out of 8,384

Massachusetts Institute of Technology

patents

17 out of 15,502

University of California

patents

5 out of 444

The Broad Institute, Inc.

patents

4. 3 out of 2,620

University of Pennsylvania

patents

5. 2 out of 2,893

The General Hospital Corporation

Strato/infusaid, Inc.

patents

9. 1 out of 576

The Salk Institute for Biological Studies

patents

10. 1 out of 712

The Rockefeller University

patents

where one patent can have more than one assignee

Years Active: 1998-2025

Loading Chart...

Areas of Expertise:

Therapeutic Peptides

Immune Tolerance

Protease Activity Profiling

CRISPR-Cas Systems

Cancer Metastasis Detection

Epithelial Cell Culturing

Biomaterials Integration

Engineered Bacteria

Nanosensors

Cancer Diagnosis

Tissue Engineering

Microfabricated Scaffolds

60 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12448418 - Activatable therapeutic peptides and uses thereof (2025-10-21),

2. 12409249 - Compositions and methods for immune tolerance (2025-09-09),

3. 12320801 - Methods to spatially profile protease activity in tissue and sections (2025-06-03),

4. 12251450 - Delivery, use and therapeutic applications of the CRISPR-Cas systems and compositions for HBV and viral diseases and disorders (2025-03-18),

5. 12173349 - Lung protease nanosensors and uses thereof (2024-12-24),

6. 11977074 - Affinity-based detection of ligand-encoded synthetic biomarkers (2024-05-07),

7. 11835522 - Sensors for detecting and imaging of cancer metastasis (2023-12-05),

8. 11788063 - Systems and methods for culturing epithelial cells (2023-10-17),

9. 11732009 - Activity sensor with tunable analyte (2023-08-22),

10. 11703510 - Methods and products for in vivo enzyme profiling (2023-07-18),

11. 11629132 - Compounds for inducing proliferation and differentiation of cells, and methods of use thereof (2023-04-18),

12. 11617817 - Biomaterials for enhanced implant-host integration (2023-04-04),

13. 11613758 - Engineered bacteria for production and release of therapeutics (2023-03-28),

14. 11549951 - Methods and products for in vivo enzyme profiling (2023-01-10),

15. 11549947 - Multiplexed detection with isotope-coded reporters (2023-01-10),

Title: The Pioneering Work of Inventor Sangeeta N Bhatia

Introduction: Sangeeta N Bhatia, a distinguished inventor based in Lexington, MA, is renowned for her groundbreaking contributions to the field of biomedical engineering.

Latest Patents: Sangeeta N Bhatia holds several patents related to innovative technologies in the areas of nanomedicine, tissue engineering, and personalized medicine.

Career Highlights: With a stellar career spanning over two decades, Sangeeta N Bhatia has received numerous accolades for her research, including being elected to the National Academy of Engineering.

Collaborations: Throughout her career, Sangeeta N Bhatia has collaborated with leading academic institutions, research centers, and biotechnology companies to further advance the frontiers of biomedical innovation.

Conclusion: Sangeeta N Bhatia's pioneering work continues to inspire the next generation of inventors and researchers in the field of biomedical engineering.

This text is generated by artificial intelligence and may not be accurate.